Company / Current Liabilities
Silo Pharma, Inc. Current Liabilities History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$1.7M
FY2025
5-year range
$116.7K / $1.7M
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $775,590 to $2M over the past 2 years.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of +70.0%.
Increased from $775,590 to $2M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +70.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +70.0%, indicating consistent growth.
- In FY2025, current liabilities increased 0.0% year-over-year.
- Lowest current liabilities in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.7M | +0.0% |
| FY2024 | $1.7M | +113.5% |
| FY2023 | $775.6K | +564.4% |
| FY2020 | $116.7K | +0.0% |
| FY2019 | $116.7K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026